Rodin Therapeutics

Develops novel therapeutics for neurological disorders by applying insights of epigenetics.

Launch date

2013

Employees

Market cap

Enterprise valuation

Cambridge Massachusetts (HQ)

Date	Investors	Amount	Round
-	GV ShangPharma Innovation Small Business Innovation Research (SBIR)	N/A	-
Jun 2013	Atlas Venture Johnson & Johnson Development Corporation	N/A	Seed
May 2014	Atlas Venture Johnson & Johnson Development Corporation	$12.9m	Series A
Jan 2016	Atlas Venture Biogen	$17.3m	Series B
Sep 2017*	Atlas Venture Hatteras Venture Partners Third Point Ventures Remeditex Ventures	$27.0m	Series C
Nov 2019	Alkermes	N/A	Acquisition
Total Funding		AUD88.4m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Rodin Therapeutics